La journée de transition

La journée de transition est une journée d’information et d’interactions qui est proposée à tous les patients qui viennent de terminer leur traitement initial du cancer du sein.

Elle est organisée autour d’ateliers en petits groupes et d'une consultation individuelle. Les principaux thèmes abordés sont : l’organisation du suivi ultérieur, l’hormonothérapie, la nutrition, l’activité physique, les aspects psychologiques et la sexualité après cancer.

Cell Biology of Organelle Networks team - Publications

back to job offer list

back to clinical trials

Recent publications

Lachuer H, Le L, Lévêque-Fort S, Goud B, Schauer K*. Spatial organization of lysosomal exocytosis relies on membrane tension gradients. Proc Natl Acad Sci U S A. 2023 Feb 21;120(8):e2207425120. doi: 10.1073/pnas.2207425120.

Cell Biology of Organelle Networks

back to job offer list

back to clinical trials

Cell Biology of Organelle Networks: Towards a high resolution map of the cancer cell

This group belongs to the UMR 1279 - Tumor cell dynamics

Biologie Cellulaire des Réseaux d’Organites

Translational Research in Hematology - main publications

back to job offer list

back to clinical trials

Main publications

Sarkozy, C. et al. (2021) Innovative therapies based on molecular orientation in patients with relapse and refractory diffuse large B-cell lymphoma: Results of LNH-EP1 study. V. Am J Hematol;96(10):E376-E379
El Halabi, L. et al. (2021) Expression of the Immune Checkpoint Regulators LAG-3 and TIM-3 in Classical Hodgkin Lymphoma. Clin Lymphoma Myeloma Leuk;21(4):257-266.

Translational Research in Hematology Platform - Team members

back to job offer list

back to clinical trials

Team members

Head of the platform: Stéphane De Botton, M.D.
Lab manager: Cyril Quivoron, PhD (cyril.quivoron@gustaveroussy.fr)
Marjorie Sabourin-Cousin, Technician
Chaima Habib Allah, Technician

Translational Research in Hematology Platform

back to job offer list

back to clinical trials

Activities

Reception and qualification of biological samples collected from patients with hematological malignancies treated at Gustave Roussy. Translational research projects are addressed after validation by lab steering committee. Research projects are proposed by the Hematology Committee or DITEP members; contracts are validated by Gustave Roussy Transfert.